The global Budesonide market is projected to grow from US$ 8487.8 million in 2024 to US$ 10250 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.

Budesonide Market

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Report Covers:

This report presents an overview of global market for Budesonide, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Budesonide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Budesonide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Budesonide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Budesonide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Budesonide sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Budesonide Market Report

Report Metric	Details
Report Name	Budesonide Market
Accounted market size in 2024	US$ 8487.8 million
Forecasted market size in 2030	US$ 10250 million
CAGR	3.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Injectable Suspension Aerosols Inhalation Powder Tablet and Capsule
Segment by Application	Respiratory Disease Treatment Nose Disease Treatment Inflammatory Bowel Disease Treatment Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Budesonide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Budesonide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Budesonide Market growing?

Ans: The Budesonide Market witnessing a CAGR of 3.2 during the forecast period 2024-2030.

What is the Budesonide Market size in 2030?

Ans: The Budesonide Market size in 2030 will be US$ 10250 million.

What is the Budesonide Market share by region?

Ans: Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

Who are the main players in the Budesonide Market report?

Ans: The main players in the Budesonide Market are Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod

What are the Application segmentation covered in the Budesonide Market report?

Ans: The Applications covered in the Budesonide Market report are Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others

What are the Type segmentation covered in the Budesonide Market report?

Ans: The Types covered in the Budesonide Market report are Injectable Suspension, Aerosols, Inhalation Powder, Tablet and Capsule

1 Study Coverage

1.1 Budesonide Product Introduction

1.2 Market by Type

1.2.1 Global Budesonide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Injectable Suspension

1.2.3 Aerosols

1.2.4 Inhalation Powder

1.2.5 Tablet and Capsule

1.3 Market by Application

1.3.1 Global Budesonide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Respiratory Disease Treatment

1.3.3 Nose Disease Treatment

1.3.4 Inflammatory Bowel Disease Treatment

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Budesonide Sales Estimates and Forecasts 2019-2030

2.2 Global Budesonide Revenue by Region

2.2.1 Global Budesonide Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Budesonide Revenue by Region (2019-2024)

2.2.3 Global Budesonide Revenue by Region (2025-2030)

2.2.4 Global Budesonide Revenue Market Share by Region (2019-2030)

2.3 Global Budesonide Sales Estimates and Forecasts 2019-2030

2.4 Global Budesonide Sales by Region

2.4.1 Global Budesonide Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Budesonide Sales by Region (2019-2024)

2.4.3 Global Budesonide Sales by Region (2025-2030)

2.4.4 Global Budesonide Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Budesonide Sales by Manufacturers

3.1.1 Global Budesonide Sales by Manufacturers (2019-2024)

3.1.2 Global Budesonide Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Budesonide in 2023

3.2 Global Budesonide Revenue by Manufacturers

3.2.1 Global Budesonide Revenue by Manufacturers (2019-2024)

3.2.2 Global Budesonide Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Budesonide Revenue in 2023

3.3 Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Budesonide Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Budesonide, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Budesonide, Product Offered and Application

3.8 Global Key Manufacturers of Budesonide, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Budesonide Sales by Type

4.1.1 Global Budesonide Historical Sales by Type (2019-2024)

4.1.2 Global Budesonide Forecasted Sales by Type (2025-2030)

4.1.3 Global Budesonide Sales Market Share by Type (2019-2030)

4.2 Global Budesonide Revenue by Type

4.2.1 Global Budesonide Historical Revenue by Type (2019-2024)

4.2.2 Global Budesonide Forecasted Revenue by Type (2025-2030)

4.2.3 Global Budesonide Revenue Market Share by Type (2019-2030)

4.3 Global Budesonide Price by Type

4.3.1 Global Budesonide Price by Type (2019-2024)

4.3.2 Global Budesonide Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Budesonide Sales by Application

5.1.1 Global Budesonide Historical Sales by Application (2019-2024)

5.1.2 Global Budesonide Forecasted Sales by Application (2025-2030)

5.1.3 Global Budesonide Sales Market Share by Application (2019-2030)

5.2 Global Budesonide Revenue by Application

5.2.1 Global Budesonide Historical Revenue by Application (2019-2024)

5.2.2 Global Budesonide Forecasted Revenue by Application (2025-2030)

5.2.3 Global Budesonide Revenue Market Share by Application (2019-2030)

5.3 Global Budesonide Price by Application

5.3.1 Global Budesonide Price by Application (2019-2024)

5.3.2 Global Budesonide Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Budesonide Market Size by Type

6.1.1 US & Canada Budesonide Sales by Type (2019-2030)

6.1.2 US & Canada Budesonide Revenue by Type (2019-2030)

6.2 US & Canada Budesonide Market Size by Application

6.2.1 US & Canada Budesonide Sales by Application (2019-2030)

6.2.2 US & Canada Budesonide Revenue by Application (2019-2030)

6.3 US & Canada Budesonide Market Size by Country

6.3.1 US & Canada Budesonide Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Budesonide Sales by Country (2019-2030)

6.3.3 US & Canada Budesonide Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Budesonide Market Size by Type

7.1.1 Europe Budesonide Sales by Type (2019-2030)

7.1.2 Europe Budesonide Revenue by Type (2019-2030)

7.2 Europe Budesonide Market Size by Application

7.2.1 Europe Budesonide Sales by Application (2019-2030)

7.2.2 Europe Budesonide Revenue by Application (2019-2030)

7.3 Europe Budesonide Market Size by Country

7.3.1 Europe Budesonide Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Budesonide Sales by Country (2019-2030)

7.3.3 Europe Budesonide Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Budesonide Market Size

8.1.1 China Budesonide Sales (2019-2030)

8.1.2 China Budesonide Revenue (2019-2030)

8.2 China Budesonide Market Size by Application

8.2.1 China Budesonide Sales by Application (2019-2030)

8.2.2 China Budesonide Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Budesonide Market Size by Type

9.1.1 Asia Budesonide Sales by Type (2019-2030)

9.1.2 Asia Budesonide Revenue by Type (2019-2030)

9.2 Asia Budesonide Market Size by Application

9.2.1 Asia Budesonide Sales by Application (2019-2030)

9.2.2 Asia Budesonide Revenue by Application (2019-2030)

9.3 Asia Budesonide Sales by Region

9.3.1 Asia Budesonide Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Budesonide Revenue by Region (2019-2030)

9.3.3 Asia Budesonide Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Budesonide Market Size by Type

10.1.1 Middle East, Africa and Latin America Budesonide Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Budesonide Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Budesonide Market Size by Application

10.2.1 Middle East, Africa and Latin America Budesonide Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Budesonide Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Budesonide Sales by Country

10.3.1 Middle East, Africa and Latin America Budesonide Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Budesonide Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Budesonide Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Information

11.1.2 AstraZeneca Overview

11.1.3 AstraZeneca Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 AstraZeneca Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AstraZeneca Recent Developments

11.2 Teva

11.2.1 Teva Company Information

11.2.2 Teva Overview

11.2.3 Teva Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Teva Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Teva Recent Developments

11.3 Mylan

11.3.1 Mylan Company Information

11.3.2 Mylan Overview

11.3.3 Mylan Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Mylan Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Mylan Recent Developments

11.4 Sandoz

11.4.1 Sandoz Company Information

11.4.2 Sandoz Overview

11.4.3 Sandoz Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Sandoz Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sandoz Recent Developments

11.5 Cosmo Pharmaceuticals

11.5.1 Cosmo Pharmaceuticals Company Information

11.5.2 Cosmo Pharmaceuticals Overview

11.5.3 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Cosmo Pharmaceuticals Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Cosmo Pharmaceuticals Recent Developments

11.6 Salix

11.6.1 Salix Company Information

11.6.2 Salix Overview

11.6.3 Salix Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Salix Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Salix Recent Developments

11.7 Chiesi Farmaceutici

11.7.1 Chiesi Farmaceutici Company Information

11.7.2 Chiesi Farmaceutici Overview

11.7.3 Chiesi Farmaceutici Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Chiesi Farmaceutici Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Chiesi Farmaceutici Recent Developments

11.8 Orion Corporation

11.8.1 Orion Corporation Company Information

11.8.2 Orion Corporation Overview

11.8.3 Orion Corporation Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Orion Corporation Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Orion Corporation Recent Developments

11.9 Cipla

11.9.1 Cipla Company Information

11.9.2 Cipla Overview

11.9.3 Cipla Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Cipla Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Cipla Recent Developments

11.10 Synmosa Biopharma

11.10.1 Synmosa Biopharma Company Information

11.10.2 Synmosa Biopharma Overview

11.10.3 Synmosa Biopharma Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Synmosa Biopharma Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Synmosa Biopharma Recent Developments

11.11 Lunan Better Pharma

11.11.1 Lunan Better Pharma Company Information

11.11.2 Lunan Better Pharma Overview

11.11.3 Lunan Better Pharma Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Lunan Better Pharma Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Lunan Better Pharma Recent Developments

11.12 Shanghai Sine Promod

11.12.1 Shanghai Sine Promod Company Information

11.12.2 Shanghai Sine Promod Overview

11.12.3 Shanghai Sine Promod Budesonide Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Shanghai Sine Promod Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Shanghai Sine Promod Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Budesonide Industry Chain Analysis

12.2 Budesonide Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Budesonide Production Mode & Process

12.4 Budesonide Sales and Marketing

12.4.1 Budesonide Sales Channels

12.4.2 Budesonide Distributors

12.5 Budesonide Customers

13 Market Dynamics

13.1 Budesonide Industry Trends

13.2 Budesonide Market Drivers

13.3 Budesonide Market Challenges

13.4 Budesonide Market Restraints

14 Key Findings in The Global Budesonide Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Cosmo Pharmaceuticals

List of Tables

Table 1. Global Budesonide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Injectable Suspension

Table 3. Major Manufacturers of Aerosols

Table 4. Major Manufacturers of Inhalation Powder

Table 5. Major Manufacturers of Tablet and Capsule

Table 6. Global Budesonide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Budesonide Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Budesonide Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Budesonide Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Budesonide Revenue Market Share by Region (2019-2024)

Table 11. Global Budesonide Revenue Market Share by Region (2025-2030)

Table 12. Global Budesonide Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Budesonide Sales by Region (2019-2024) & (M Units)

Table 14. Global Budesonide Sales by Region (2025-2030) & (M Units)

Table 15. Global Budesonide Sales Market Share by Region (2019-2024)

Table 16. Global Budesonide Sales Market Share by Region (2025-2030)

Table 17. Global Budesonide Sales by Manufacturers (2019-2024) & (M Units)

Table 18. Global Budesonide Sales Share by Manufacturers (2019-2024)

Table 19. Global Budesonide Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Budesonide Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Budesonide Price by Manufacturers 2019-2024 (USD/K Units)

Table 23. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2023)

Table 25. Global Key Manufacturers of Budesonide, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Budesonide, Product Offered and Application

Table 27. Global Key Manufacturers of Budesonide, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Budesonide Sales by Type (2019-2024) & (M Units)

Table 30. Global Budesonide Sales by Type (2025-2030) & (M Units)

Table 31. Global Budesonide Sales Share by Type (2019-2024)

Table 32. Global Budesonide Sales Share by Type (2025-2030)

Table 33. Global Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Budesonide Revenue Share by Type (2019-2024)

Table 36. Global Budesonide Revenue Share by Type (2025-2030)

Table 37. Budesonide Price by Type (2019-2024) & (USD/K Units)

Table 38. Global Budesonide Price Forecast by Type (2025-2030) & (USD/K Units)

Table 39. Global Budesonide Sales by Application (2019-2024) & (M Units)

Table 40. Global Budesonide Sales by Application (2025-2030) & (M Units)

Table 41. Global Budesonide Sales Share by Application (2019-2024)

Table 42. Global Budesonide Sales Share by Application (2025-2030)

Table 43. Global Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Budesonide Revenue Share by Application (2019-2024)

Table 46. Global Budesonide Revenue Share by Application (2025-2030)

Table 47. Budesonide Price by Application (2019-2024) & (USD/K Units)

Table 48. Global Budesonide Price Forecast by Application (2025-2030) & (USD/K Units)

Table 49. US & Canada Budesonide Sales by Type (2019-2024) & (M Units)

Table 50. US & Canada Budesonide Sales by Type (2025-2030) & (M Units)

Table 51. US & Canada Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Budesonide Sales by Application (2019-2024) & (M Units)

Table 54. US & Canada Budesonide Sales by Application (2025-2030) & (M Units)

Table 55. US & Canada Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Budesonide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Budesonide Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Budesonide Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Budesonide Sales by Country (2019-2024) & (M Units)

Table 61. US & Canada Budesonide Sales by Country (2025-2030) & (M Units)

Table 62. Europe Budesonide Sales by Type (2019-2024) & (M Units)

Table 63. Europe Budesonide Sales by Type (2025-2030) & (M Units)

Table 64. Europe Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Budesonide Sales by Application (2019-2024) & (M Units)

Table 67. Europe Budesonide Sales by Application (2025-2030) & (M Units)

Table 68. Europe Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Budesonide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Budesonide Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Budesonide Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Budesonide Sales by Country (2019-2024) & (M Units)

Table 74. Europe Budesonide Sales by Country (2025-2030) & (M Units)

Table 75. China Budesonide Sales by Type (2019-2024) & (M Units)

Table 76. China Budesonide Sales by Type (2025-2030) & (M Units)

Table 77. China Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Budesonide Sales by Application (2019-2024) & (M Units)

Table 80. China Budesonide Sales by Application (2025-2030) & (M Units)

Table 81. China Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Budesonide Sales by Type (2019-2024) & (M Units)

Table 84. Asia Budesonide Sales by Type (2025-2030) & (M Units)

Table 85. Asia Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Budesonide Sales by Application (2019-2024) & (M Units)

Table 88. Asia Budesonide Sales by Application (2025-2030) & (M Units)

Table 89. Asia Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Budesonide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Budesonide Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Budesonide Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Budesonide Sales by Region (2019-2024) & (M Units)

Table 95. Asia Budesonide Sales by Region (2025-2030) & (M Units)

Table 96. Middle East, Africa and Latin America Budesonide Sales by Type (2019-2024) & (M Units)

Table 97. Middle East, Africa and Latin America Budesonide Sales by Type (2025-2030) & (M Units)

Table 98. Middle East, Africa and Latin America Budesonide Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Budesonide Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Budesonide Sales by Application (2019-2024) & (M Units)

Table 101. Middle East, Africa and Latin America Budesonide Sales by Application (2025-2030) & (M Units)

Table 102. Middle East, Africa and Latin America Budesonide Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Budesonide Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Budesonide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Budesonide Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Budesonide Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Budesonide Sales by Country (2019-2024) & (M Units)

Table 108. Middle East, Africa and Latin America Budesonide Sales by Country (2025-2030) & (M Units)

Table 109. AstraZeneca Company Information

Table 110. AstraZeneca Description and Major Businesses

Table 111. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 112. AstraZeneca Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. AstraZeneca Recent Developments

Table 114. Teva Company Information

Table 115. Teva Description and Major Businesses

Table 116. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 117. Teva Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Teva Recent Developments

Table 119. Mylan Company Information

Table 120. Mylan Description and Major Businesses

Table 121. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 122. Mylan Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Mylan Recent Developments

Table 124. Sandoz Company Information

Table 125. Sandoz Description and Major Businesses

Table 126. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 127. Sandoz Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Sandoz Recent Developments

Table 129. Cosmo Pharmaceuticals Company Information

Table 130. Cosmo Pharmaceuticals Description and Major Businesses

Table 131. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 132. Cosmo Pharmaceuticals Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Cosmo Pharmaceuticals Recent Developments

Table 134. Salix Company Information

Table 135. Salix Description and Major Businesses

Table 136. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 137. Salix Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Salix Recent Developments

Table 139. Chiesi Farmaceutici Company Information

Table 140. Chiesi Farmaceutici Description and Major Businesses

Table 141. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 142. Chiesi Farmaceutici Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Chiesi Farmaceutici Recent Developments

Table 144. Orion Corporation Company Information

Table 145. Orion Corporation Description and Major Businesses

Table 146. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 147. Orion Corporation Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Orion Corporation Recent Developments

Table 149. Cipla Company Information

Table 150. Cipla Description and Major Businesses

Table 151. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 152. Cipla Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Cipla Recent Developments

Table 154. Synmosa Biopharma Company Information

Table 155. Synmosa Biopharma Description and Major Businesses

Table 156. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 157. Synmosa Biopharma Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. Synmosa Biopharma Recent Developments

Table 159. Lunan Better Pharma Company Information

Table 160. Lunan Better Pharma Description and Major Businesses

Table 161. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 162. Lunan Better Pharma Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 163. Lunan Better Pharma Recent Developments

Table 164. Shanghai Sine Promod Company Information

Table 165. Shanghai Sine Promod Description and Major Businesses

Table 166. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 167. Shanghai Sine Promod Budesonide Product Model Numbers, Pictures, Descriptions and Specifications

Table 168. Shanghai Sine Promod Recent Developments

Table 169. Key Raw Materials Lists

Table 170. Raw Materials Key Suppliers Lists

Table 171. Budesonide Distributors List

Table 172. Budesonide Customers List

Table 173. Budesonide Market Trends

Table 174. Budesonide Market Drivers

Table 175. Budesonide Market Challenges

Table 176. Budesonide Market Restraints

Table 177. Research Programs/Design for This Report

Table 178. Key Data Information from Secondary Sources

Table 179. Key Data Information from Primary Sources

List of Figures

Figure 1. Budesonide Product Picture

Figure 2. Global Budesonide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Budesonide Market Share by Type in 2023 & 2030

Figure 4. Injectable Suspension Product Picture

Figure 5. Aerosols Product Picture

Figure 6. Inhalation Powder Product Picture

Figure 7. Tablet and Capsule Product Picture

Figure 8. Global Budesonide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Budesonide Market Share by Application in 2023 & 2030

Figure 10. Respiratory Disease Treatment

Figure 11. Nose Disease Treatment

Figure 12. Inflammatory Bowel Disease Treatment

Figure 13. Others

Figure 14. Budesonide Report Years Considered

Figure 15. Global Budesonide Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Budesonide Revenue 2019-2030 (US$ Million)

Figure 17. Global Budesonide Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Budesonide Revenue Market Share by Region (2019-2030)

Figure 19. Global Budesonide Sales 2019-2030 ((M Units)

Figure 20. Global Budesonide Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Budesonide Sales YoY (2019-2030) & (M Units)

Figure 22. US & Canada Budesonide Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Budesonide Sales YoY (2019-2030) & (M Units)

Figure 24. Europe Budesonide Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Budesonide Sales YoY (2019-2030) & (M Units)

Figure 26. China Budesonide Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Budesonide Sales YoY (2019-2030) & (M Units)

Figure 28. Asia (excluding China) Budesonide Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Budesonide Sales YoY (2019-2030) & (M Units)

Figure 30. Middle East, Africa and Latin America Budesonide Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Budesonide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Budesonide in the World: Market Share by Budesonide Revenue in 2023

Figure 33. Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Budesonide Sales Market Share by Type (2019-2030)

Figure 35. Global Budesonide Revenue Market Share by Type (2019-2030)

Figure 36. Global Budesonide Sales Market Share by Application (2019-2030)

Figure 37. Global Budesonide Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Budesonide Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Budesonide Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Budesonide Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Budesonide Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Budesonide Revenue Share by Country (2019-2030)

Figure 43. US & Canada Budesonide Sales Share by Country (2019-2030)

Figure 44. U.S. Budesonide Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Budesonide Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Budesonide Sales Market Share by Type (2019-2030)

Figure 47. Europe Budesonide Revenue Market Share by Type (2019-2030)

Figure 48. Europe Budesonide Sales Market Share by Application (2019-2030)

Figure 49. Europe Budesonide Revenue Market Share by Application (2019-2030)

Figure 50. Europe Budesonide Revenue Share by Country (2019-2030)

Figure 51. Europe Budesonide Sales Share by Country (2019-2030)

Figure 52. Germany Budesonide Revenue (2019-2030) & (US$ Million)

Figure 53. France Budesonide Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Budesonide Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Budesonide Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Budesonide Revenue (2019-2030) & (US$ Million)

Figure 57. China Budesonide Sales Market Share by Type (2019-2030)

Figure 58. China Budesonide Revenue Market Share by Type (2019-2030)

Figure 59. China Budesonide Sales Market Share by Application (2019-2030)

Figure 60. China Budesonide Revenue Market Share by Application (2019-2030)

Figure 61. Asia Budesonide Sales Market Share by Type (2019-2030)

Figure 62. Asia Budesonide Revenue Market Share by Type (2019-2030)

Figure 63. Asia Budesonide Sales Market Share by Application (2019-2030)

Figure 64. Asia Budesonide Revenue Market Share by Application (2019-2030)

Figure 65. Asia Budesonide Revenue Share by Region (2019-2030)

Figure 66. Asia Budesonide Sales Share by Region (2019-2030)

Figure 67. Japan Budesonide Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Budesonide Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Budesonide Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Budesonide Revenue (2019-2030) & (US$ Million)

Figure 71. India Budesonide Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Budesonide Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Budesonide Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Budesonide Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Budesonide Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Budesonide Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Budesonide Sales Share by Country (2019-2030)

Figure 78. Brazil Budesonide Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Budesonide Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Budesonide Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Budesonide Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Budesonide Revenue (2019-2030) & (US$ Million)

Figure 83. Budesonide Value Chain

Figure 84. Budesonide Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions